MissionIRNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) at the Forefront of Modernizing Immunology

Diversified clinical-stage immunology company INmune Bio (NASDAQ: INMB) is on a mission to develop novel immunotherapies that reprogram patients’ innate immune systems to enable them to fight cancer and Alzheimer’s disease. A recent article further discussing the company reads, “Innate is an immediate, nonspecific, initial response that serves as a first line of defense against infection and cancer. Most drug-development programs concentrate on the adaptive immune response and ignore innate immunity. INmune Bio harnesses the innate immune system with a targeted biomarker approach. . . . The company’s INKmune drug is a biologic therapy. INKmune primes NK cells to eliminate minimal residual disease, which is a major cause of cancer relapse and death. NK cells play a vital role in preventing cancer. Later this year, the company expects to begin enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer.”

To view the full article, visit http://ibn.fm/Yvjtc

About INmune Bio Inc.

INmune Bio Inc. (NASDAQ: INMB) is a publicly traded, clinical-stage biotechnology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing three product platforms: two products that re-engineer the patient’s innate immune system’s response to cancer and one product to treat neuroinflammation that is currently focused on Alzheimer’s disease. INKmune is a natural killer (“NK”) cell therapeutic that primes the patient’s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INB03 inhibits myeloid derived suppressor cells (“MDSC”), which often cause resistance to immunotherapy, such as anti-PD-1 checkpoint inhibitors. XPro1595 targets neuroinflammation, which causes microglial activation and neuronal cell death. INmune Bio’s product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and chronic inflammation. To learn more, please visit www.INmuneBio.com.

NOTE TO INVESTORS: The latest news and updates relating to INMB are available in the company’s newsroom at http://ibn.fm/INMB

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Details Modesto Facility in Video Tour

TransCanna Holdings (CSE: TCAN) (FSE: TH8) recently acquired a 196,000-square-foot, self-contained production and distribution facility in Modesto, California. A recent article discussing the company reads, “The Modesto facility will serve as a production hub that enables TransCanna to cultivate and deliver the 15 brands to scale as the company grows over time. TransCanna recently produced an eight-minute video as a quick tour of the facility (http://ibn.fm/2O53U), which is part of a larger 5.5-acre property purchase that the company can develop with an additional, still-larger structure to grow its own biomass. As it is, the current facility has space for a significant-sized nursery, as well as grow, manufacturing, bottling, baking, extraction and transportation operations. . . . ‘The benefit here is that we have better temperature control, better humidity control. We don’t bring any outside air into any of the controlled environments inside the facility. So it really differentiates us from anybody else in the industry,’ Pakulis said during the video tour of the existing structure. ‘And it was specifically designed for this facility by the sellers. And the sellers, for the last 25 years, have designed these systems for food-grade processing facilities throughout the United States. . . . It is truly a vertically integrated facility.’”

To view the full article, visit http://ibn.fm/WKYFM

About TransCanna Holdings Inc.

TransCanna Holdings is a Canadian-based company focused on providing integrated branding, transportation and distribution services through its wholly owned California subsidiaries to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://ibn.fm/TCAN

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Launches Novel System to Revolutionize High Quality, Water-Soluble CBD Manufacturing

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the launch of its BaroShear(TM) K45 system based on PBIO’s proprietary Ultra Shear Technology(TM) (“UST”) platform. Per the update, the unique, next generation BaroShear K45 system is designed to fix one of the most critical problems facing CBD manufacturers today – the extremely poor water solubility of CBD oil. “The unique concept of the BaroShear K45 system is based on PBI’s proprietary UST platform. It was designed for the efficient and affordable manufacture of limited quantity oil-based material into high quality, water-soluble nanoemulsions,” PBIO Senior Advisor Dr. Nathan Lawrence said in the news release. “The BaroShear K45 system uses a custom-designed, highly responsive ultra-high pressure generating subsystem, matched to our patented BaroIsolator(TM) device and NanoGap(TM) valve. This allows for the highest effectiveness possible at working pressures up to 45,000 psi. The BaroShear K45 system is ideally suited for processing small amounts (e.g., 50 mL – 2 L) of high value product, such as CBD oil, into nanoemulsions with high yield.”

To view the full press release, visit http://ibn.fm/DXUX9

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Launches Strategic Hemp Division

• The Green Organic Dutchman’s focus is on being the market’s foremost global organic cannabis brand
• The company recently launched a worldwide strategic hemp division
• TGOD aims to provide a suite of premium consumer-preferred products

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is a premium cannabis company that grows high-quality, organic cannabis with sustainable, all-natural principles. Established in 2012, TGOD focuses on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, along with the Canadian adult-use market. TGOD’s senior management team has wide-ranging experience in executive and operational activities specific to CPG (consumer packaged goods), consumer products, and the cannabis and finance industries.

TGOD’s products are laboratory tested to ensure that patients have access to a standardized, safe and consistent product. Headquartered in Mississauga, Ontario, TGOD has a planned capacity of 219,000 kg and is building 1,643,600 square feet of cultivation and processing facilities across the Canadian provinces of Ontario and Quebec, as well as in Jamaica and Denmark.

Recently, TGOD launched a global strategic hemp division, through which it plans to expand into the worldwide organic hemp market in a significant way. The company previously entered the flourishing European hemp market via joint ventures, along with its 2018 acquisition of HemPoland, a company with extensive experience in the European CBD (cannabidiol) market (http://ibn.fm/ilTR2). TGOD itself has considerable experience from which to significantly ramp up expansion plans. The company’s global strategic hemp division will work to expand into territories in Canada, Jamaica, Poland, Mexico and the United States. TGOD’s stock rose after the announcement of the company’s new division.

HemPoland has vast experience in cultivating and processing EU-registered hemp varieties that are similar to those now allowed for cultivation in Canada. HemPoland’s revenue for Q1 increased by almost 30 percent quarter over quarter as demand for high-quality hemp CBD products in Europe gained momentum (http://ibn.fm/7uVeD). TGOD’s global strategic hemp division will be tasked with providing genetics, training on organic methods and standard operating procedures, and regulatory insights and other advisory support to the company’s global partners.

“With the global CBD market expected to hit $22 billion in less than three years, it is clear that the segment is drawing substantial consumer demand,” TGOD CEO Brian Athaide stated in a news release. “Our team has years of direct hands-on experience in the CBD space, and we are excited to use this advantage to execute on a fast-moving market expansion strategy. CBD is a wellness product and has a natural fit with TGOD’s certified organic positioning and the large segment of consumers who are increasingly demanding natural and organic products.”

In addition, TGOD has partnered with Eaton Corp., a global power-management company that is providing research and optimization. This partnership will allow TGOD to have some of the lowest electricity input costs in the business. TGOD also has a partnership with Canada’s second-largest construction management company, Ledcor.

TGOD has a facility in Ancaster, Ontario, with a funded expansion of 166,000 square feet capable of producing 17,500 kg of high-quality organic cannabis annually. Plans also include a 20,000-square-foot enclosed facility, which will add 2,000 kg of capacity to the company’s projected output. In addition, TGOD has more than 1.4 million square feet planned internationally (http://ibn.fm/TdzJj). Furthermore, the expectation is that the company’s strategic beverage division will be an organic R&D center for novel and proprietary cannabinoid-infused beverages, advanced products, advanced-product development and pilot manufacturing.

Growing to scale with logistical and infrastructure controls, TGOD represents a compelling investment opportunity for investors wanting a position in the premium organic cannabis market. The company continues to focus on creating novel and proprietary strains and differentiated products. TGOD is actively pursuing its mission to provide organic cannabis solutions to enhance people’s lives.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Earth Science Tech Inc. (ETST) Builds a Niche in Expansive Wellness Industry with Women’s Health, CBD Products

• Earth Science Tech is a Florida-based company with a vision of enhancing the quality of people’s lives through varied wellness initiatives as part of a growing $4.2 trillion industry
• The company’s two subsidiaries have a targeted focus on helping women who might not normally pursue health care to assess and treat STIs, as well as on utilizing hemp derivatives as therapy for a variety of maladies
• ETST also supports a favored entity’s efforts to gain non-profit status for accepting grants that would further CBD studies and assist the company in donating its products on the basis of need

The health and wellness industry continues to accelerate annual sales of products and philosophies designed to help people live life and love it, propelled in large part by concerns about the rising costs of health care and the decrease in age of patients reporting select chronic ailments, including heart disease. The Global Wellness Institute reports that wellness industry revenues increased by 6.4 percent annually from 2015-17 to become a $4.2 trillion market that is growing nearly twice as fast as the global economy (http://ibn.fm/afG7j).

Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) has built a variety of partnerships that support its two wholly owned subsidiaries, as well as a favored non-profit entity, in their endeavors to advance consumers’ wellbeing. The company’s mission is focused on cannabis/industrial hemp and medical devices.

Subsidiary Earth Science Pharmaceutical is committed to bringing low-cost, non-invasive testing processes and vaccines for sexually transmitted infections to market to help women improve the quality of their lives. The company’s first medical device, Hygee, is a home kit designed as a modified panty liner to allow for the self-collection of a gynecological specimen that can be tested for two types of infections – chlamydia and gonorrhea. It gives women the ability to self-collect specimens in a non-clinical setting before sending them to a laboratory that will process the specimens and notify them if they test positive so that they can seek treatment.

The motivation behind the technology is to help women and girls in high-risk situations, who might not be willing or able to seek out assistance through traditional medical care facilities, take responsible action for their own wellbeing with the help of online ordering and home screening.

ETST’s second subsidiary, Cannabis Therapeutics, is investing in the medicinal power of hemp-derived cannabidiol (CBD). Earth Science Tech holds three provisional application patents for a CBD product that the company aims to use in developing treatments for breast and ovarian cancers, and for two generic pharmaceutical drugs with a CBD foundation.

Industrial hemp-based CBD and full-spectrum oils provide the company a core operation with increasing revenues, but Earth Science Tech has also been invested in research and developmental lab work that it hopes to continue for advancing varied high-quality natural hemp extracts and identifying their distinct properties. In addition to breast and ovarian cancer treatments, the company aims to further non-prescription therapies for chronic pain, joint pain, inflammation, seizures, high blood pressure, memory loss, depression, weight management, nausea and general aging-related maladies.

ETST’s formulations are expected to include options such as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs and may include products such as CBD as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products (http://ibn.fm/5Hokn).

As a companion entity to Earth Science Tech’s subsidiary operations, the company backs favored entity Earth Science Foundation’s effort to become a non-profit organization that can accept grants and donations to conduct further studies and assist in donating Earth Science Tech’s effective CBD products to those in need.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Expands Partnership with Abercrombie & Fitch (NYSE: ANF) to Sell Seventh Sense CBD Products in over 160 Stores

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced expansion of its partnership with Abercrombie & Fitch (“A&F”), a division of Abercrombie & Fitch Co. (NYSE: ANF). According to the update, the specialty retailer, which trialed GGB’s Seventh Sense Botanical Therapy products in 10 Abercrombie & Fitch locations, will now carry the CBD products in more than 160 A&F stores. The expansion is Green Growth Brands’ second major wholesale agreement since the passage of the Agriculture Act of 2018 and includes Seventh Sense’s CBD-infused body lotions, muscle balms, lip balms and sugar scrubs. “Abercrombie & Fitch understands how to connect with their target-customer, not just in the U.S. but across the globe,” Green Growth Brands CEO Peter Horvath said in the news release. “They have incredible brand recognition in our current target markets and beyond, and we are excited at the prospect of building our partnership together.”

To view the full press release, visit http://ibn.fm/irh5M

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S., its CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd.’s (TSX: TGOD) (OTCQX: TGODF) Valleyfield Facility Secures Organic Certification from Pro-Cert

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that its flagship Valleyfield, QC facility has received organic certification from Pro-Cert, a globally recognized leader in organic certification. Upon completion, TGOD’s Valleyfield site will be the largest organic cannabis facility in the world with over 1.3 million square feet. “It’s exciting to reach new milestones as we begin commercial production. Growing certified organic cannabis at scale is a highly complex process which has taken time, great care and extensive research to refine. Each of our facilities goes through a robust certification process, in line with the high standards we have set, ensuring operational excellence at all stages,” TGODF CEO Brian Athaide stated in the news release. “The proprietary methods our team has developed leverage the benefits of growing in living soil and guarantees the organic integrity of the products throughout the entire production chain.”

To view the full press release, visit http://ibn.fm/aVglm

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium, global, organic-cannabis company with operations focused on medical-cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic-hemp, CBD-oil operations in Canada and, through its wholly owned subsidiary HemPoland, distributes premium-hemp CBD oil in the European Union. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe, consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

ChineseInvestors.com Inc. (CIIX) CEO Sees Planned Merger, Acquisition Activity as Key to Future

• CIIX anticipates growth in the Asian region via merger and acquisition activities
• The company’s CEO expects sales to double over the next 12 months
• CIIX’s core business for years has been focused on educational services and delivering financial and investment news in real-time

ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang said, in a Redchip Money Report interview with host Dave Gentry, that investors should know that CIIX is seeking to expand its future business via merger and acquisition activities in the Asian region (http://ibn.fm/SVdPq).

During the interview, Wang projected CIIX’s sales to double over the next 12 months. Wang noted that the company has long been reaching a Chinese-speaking audience in the United States and Canada with investment information on issues ranging from cryptocurrency to CBD.

“We are going to do some merger/acquisition to expand our business in the Asian region,” Wang said in the interview. CIIX is a multifaceted company, driven not only by educational services but also by sales of cosmetics, hemp wine and CBD. At retail, CIIX operates a pop-up store in California at the Glendale Galleria Mall.

CIIX maintains a website, ChineseFN.com, that has a following of more than 100,000 registered users and 5,000 subscribers, according to Wang. The site offers its audience up-to-date analysis on currencies and other financial information.

Wang explained that there are more than four million Chinese Americans and Chinese Canadians in North America, and CIIX plans to expend additional advertising dollars to grow its retail businesses, both online and in-person.

CIIX is a diversified company that offers its audience of Chinese-speaking investors real-time market commentary, analysis and education-related services in Chinese character language sets.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Achieves First Major Milestone in Potential Breakthrough Processing Method for Higher Quality, Safer Foods and Beverages

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, this morning announced the first major milestone achievement in its collaboration with the College of Food, Agricultural, and Environmental Sciences (“CFAES”) of The Ohio State University. According to the update, the program’s primary goal is to develop and make available for commercialization a continuous-flow manufacturing process to prepare foods and beverages with superior nutritional and sensory qualities and long, room temperature shelf stability without the requirement for refrigeration or chemical additives. The company believes that, through scale-up of its innovative and patented Ultra Shear Technology(TM) (“UST”) platform, it can achieve this highly sought-after consumer demand. “We are very excited to have met this first major milestone. We believe our proprietary UST platform can be used to make the higher quality, more nutritious, longer-lasting foods that consumers now demand,” PBIO Sr. VP of Engineering Dr. Edmund Y. Ting said in the news release. “The UST-based bench-top instrument – together with the larger scale, floor model, higher capacity instrument we are now developing – will be used to generate the fundamental food science quality and safety validation data that we believe will enable future process adoption by industry and acceptance by the regulators.”

To view the full press release, visit http://ibn.fm/rxN0b

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Continues to Transform Cannabis Landscape with Novel Products, Technology

• A partnership with PAX will allow Organigram to manufacture and fill pods for the premium, technology-based PAX Era vaporizer
• The PAX partnership is expected to enable the two entities to seize new opportunities on the market and work together to develop premium products featuring disruptive, industry-leading technology that is set to redefine the experience of vaping
• An agreement signed with Feather Company Ltd. makes Organigram the exclusive Canadian supplier of unique and proprietary vaporizer pen technology
• Organigram is selling to all 10 Canadian provinces
• The company is on track to increase production capacity and is well positioned for Canada’s new edibles and derivative legislation, slated for October 2019

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI), a leading Canadian licensed producer (LP) of high-quality cannabis and extract-based products, continues to develop exclusive partnerships and introduce innovative products that enhance the cannabis lifestyle for its customers. An exclusive agreement signed with Feather Company Ltd. illustrates this laser focus on customer experience as Organigram looks forward to Canada’s legalization of new cannabis product categories, as the company stated in a news release (http://ibn.fm/T4kfV).

“A successful recreational cannabis market requires that licensed producers and their partners continually reimagine the cannabis experience,” Ray Gracewood, senior vice president, marketing and communications for Organigram, stated in the release. “It is critical for Organigram to find unique ways to offer customers the kind of value that will help differentiate our brands. The future is in providing unique opportunities for customers to explore the product.”

The exclusive agreement between Organigram and Feather, a cannabis innovator and lifestyle brand committed to the production of premium-quality products, creates a mutually beneficial relationship for the two companies. Organigram, through its Edison Cannabis Co. brand, will hold an exclusive license to Feather’s proprietary vaporizer pen technology and form factor. Organigram will also represent Feather across Canada from a commercial perspective and plans to approach all 10 provinces with Feather’s disposable and cartridge-based units.

“We are thrilled to be working with Organigram,” Feather CEO Patrick Lehoux stated in the release. “As patients, enthusiasts and advocates for the cannabis community, we are committed to applying our diverse skills to produce the best experience for consumers. Our partnership with Organigram opens new and exciting opportunities for us to do just that. We believe in the Edison brand and Organigram’s best-in-class facility ensures that we are partnered with a team committed to producing a consistent, premium product.”

The disposable vaporizer pen and 5/10 thread cartridges for targeted adult-use customer segments are expected to be available as this product category becomes legal in Canada by mid-October 2019. Feather’s technology and hardware offers Organigram’s Edison brand a unique, proprietary delivery mechanism for discerning and sophisticated consumers and will complement the company’s partnership with PAX, a leader in closed-loop vaporizable technology offered through the PAX Era product line  (http://ibn.fm/lXIpJ).

Organigram is planning on working with and offering the Edison Cannabis Co.-branded PAX Era pods to all 10 of its provincial partners to achieve coast-to-coast distribution. The pods will be filled onsite at Organigram’s Moncton facility at the company’s phase 5 refurbishment.

As concentrates are anticipated to become legal in Canada later in 2019, giving birth to a wide range of new market development opportunities, strategic partnerships like the one between Organigram and PAX Labs are expected to allow the immediate launch of premium products featuring a disruptive, industry-leading technology that is set to redefine the experience of vaping.

“Cannabis 2.0 – the next generation of legal, adult use cannabis products – represents a world of opportunity,” Organigram CEO Greg Engel added. “Innovative partnerships with exceptional companies like PAX mean our own product offering grows and our customers have access to cutting-edge technology and cannabis experiences.”

The agreement with PAX reflects Organigram’s strategic commitment to growth and leadership through technology-driven innovation. Additionally, the company has been building up significant levels of concentrate in anticipation of the Canadian legislative change and the launch of Cannabis 2.0 vape pens and edibles later in 2019. According to Engel, this is just the beginning for his company, whose team is strongly committed to developing exceptional and imaginative products that support both the organization’s business objectives and its customers’ needs.

Further cementing its position, Organigram earlier in 2019 secured distribution agreements in all 10 Canadian provinces, becoming one of just three licensed producers in Canada to do so (http://ibn.fm/NCowK). The company boasts the lowest cost of cultivation among Canadian licensed producers, driven by industry-leading yields.

For more information, visit the company’s website at www.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

ChineseInvestors.com Inc. (CIIX) Sees Huge Market Opportunity

• CIIX is the first CBD company to focus on Chinese-speaking North Americans
• The company is targeting a huge market opportunity in China and throughout Asia
• CIIX sales are projected to double over the next 12 months

ChineseInvestors.com Inc. (OTCQB: CIIX) provides Chinese-speaking investors in the U.S., Canada and Asia with real-time market commentary, analysis and education-related services in the Chinese language. The company has a highly diversified revenue stream and is seeing a huge market opportunity for its cannabinoid products, as well as expanding into cryptocurrency and blockchain educational services.

In 2019, CIIX experienced an 81 percent revenue increase, which CEO Warren Wang attributed mainly to the company’s hemp CBD sales. The company is standing at the forefront of this market as the first CBD company to focus on the more than four million Chinese-speaking Americans and Canadians.

On May 1, 2019, under wholly owned subsidiary ChineseHempOil.com, which has been doing business in the United States since 2017 as Chinese Wellness Center (CWC), the company opened its first mall pop-up kiosk. The kiosk offers customers CWC’s OptHemp product line and additional CBD products including NuLeaf Naturals, Joy Organics, Medterra, Hemp Meds and Medix.

Right now, a huge market opportunity exists in China and throughout Asia. The Chinese consumer has high spending power, and regulations are in favor of CBD products in China. CIIX reports additional mergers and acquisitions in the planning stages in Asia.

By focusing on the American market and opportunities in China and Asia, the company’s sales are projected to double over the next 12 months, Wang noted in a news release (http://ibn.fm/2UeEH). U.S. consumer sales of CBD are anticipated to reach $1.8 billion by 2022, increasing drastically from the $500 million seen in 2018 (http://ibn.fm/q72dL). The industry is rapidly growing, and CIIX has positioned itself strategically as the first publicly traded Chinese company to offer CBD to an American market.

CIIX’s main focus is on providing financial information and services to the global Chinese community. The company continues to develop and market web-based tools to educate and inform while providing added value to an everchanging market. The following educational tools are provided in the Chinese language character set:

• Da Ma Dian Ping is a cannabis-focused mobile app that’s currently in the developmental stage. This app will aim to provide Chinese speakers worldwide with the ability to review and discuss cannabis products.
• www.NewCoins168.com is a free portal that offers news and investment education covering cryptocurrency and blockchain.
• www.ChineseInvestors.com is the company’s primary site, offering real-time market information and educational services.
• www.ChineseFN.com offers daily financial investment news and has 5,000 subscribers and more than 100,000 registered users.

For more information, visit the company’s website at www.ChineseInvestors.com

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://ibn.fm/CIIX

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Appoints Proven Consumer Marketing Expert Jann Parish as CMO

Lifestyle-oriented cannabis company Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) today announced its appointment of Jann Parish as chief marketing officer (“CMO”), effective immediately. Formerly CMO of Victoria’s Secret and other global brands, and the recipient of numerous awards, Parish brings to the company brand development, strategic consumer relationship management and digital innovation. “As GGB continues rapid expansion in both the CBD and MSO segments, we are delighted to be bringing Jann, a proven consumer marketing expert, onboard,” Green Growth Brands CEO Peter Horvath said in the news release. “Jann is a master at positioning brands to resonate with consumers. As we scale our portfolio of brands, I am confident that under her leadership we will be differentiated from the competition.  We are so pleased to welcome Jann to the team.”

To view the full press release, visit http://ibn.fm/C1WXw

About Green Growth Brands

Green Growth Brands creates remarkable experiences in cannabis and CBD. Led by CEO Peter Horvath and a leadership team of consumer-focused retail experts, the company’s brands include CAMP, Seventh Sense Botanical Therapy, The+Source, Green Lily, and Meri + Jayne. The company also has a licensing agreement with the Greg Norman(TM) Brand to develop a line of CBD-infused personal care products designed for active wellness. Already driving the strongest sales per square feet in the cannabis industry, GGB is expanding its cannabis operations throughout the U.S., its CBD presence at ShopSeventhSense.com, in malls across the country and at DSW shoe stores—and that’s just the beginning. For more information, visit the company’s website at www.GreenGrowthBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GGBXF are available in the company’s newsroom at http://ibn.fm/GGBXF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Health Canada Approval for Additional 17 Licensed Cultivation Rooms

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) today announced its receipt of Health Canada approval for the licensing of 17 additional cultivation rooms within its facility’s Phase 4A/4B perimeter. According to the update, approval of the additional licensed cultivation space increases annual target production capacity to 61,000 kg. “Sustainable growth, exceptional quality and constant innovation are the pillars of our overall strategic approach,” Organigram CEO Greg Engel said in the news release. “We are proud to continue to increase our physical capacity to meet the needs of cannabis consumers across the country while also bringing new thinking and technology to our production.”

To view the full press release, visit http://ibn.fm/o8YCq

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange and NASDAQ Global Select listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca

NOTE TO INVESTORS: The latest news and updates relating to OGI are available in the company’s newsroom at http://ibn.fm/OGRMF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html